Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sjögren syndrome.

Sathish Srinivasan1, Allan R Slomovic

  • 1Department of Ophthalmology, Toronto Western Hospital, and Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada. sathish.srinivasan@gmail.com

Comprehensive Ophthalmology Update
|November 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regenerative Ophthalmology: A Paradigm Change.

American journal of ophthalmology·2026
Same author

Efficacy and safety of aselective laser device to create centred capsulotomies in white intumescent cataracts: international multicentre study (LC-WIC study).

Journal of cataract and refractive surgery·2026
Same author

Hepatocellular carcinoma: PIVKA-II may be unsuitable for Indian patients.

Laboratory medicine·2025
Same author

That's a wrap-2025.

Journal of cataract and refractive surgery·2025
Same author

Long-term trends in bacterial keratitis in Toronto: a 21-year retrospective review.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2025
Same author

Meta-analysis of defocus curves of monofocal, enhanced monofocal and extended depth of focus IOLs.

BMJ open ophthalmology·2025
Same journal

Persistent corneal ulcer.

Comprehensive ophthalmology update·2008
Same journal

Gonioscopy.org: a video Atlas.

Comprehensive ophthalmology update·2008
Same journal

Pay for performance: is it ethical?

Comprehensive ophthalmology update·2008
Same journal

Review of sulfonamide-induced acute myopia and acute bilateral angle-closure glaucoma.

Comprehensive ophthalmology update·2008
Same journal

Intravitreal pharmacotherapy: applications in retinal disease.

Comprehensive ophthalmology update·2008
Same journal

Comments on: management of proliferative diabetic retinopathy.

Comprehensive ophthalmology update·2008
See all related articles

Sjögren syndrome is an autoimmune disorder affecting exocrine glands. This review covers recent advances in understanding its mechanisms and therapeutic options for managing symptoms like dry eye.

Area of Science:

  • Immunology
  • Rheumatology
  • Ophthalmology

Background:

  • Sjögren syndrome is a chronic autoimmune disorder characterized by lymphocytic infiltration of exocrine glands.
  • It can manifest as primary Sjögren syndrome or secondary to other autoimmune conditions like rheumatoid arthritis, systemic lupus erythematosus, and progressive systemic sclerosis.
  • A revised international consensus aids in diagnosis based on symptoms and objective signs.

Purpose of the Study:

  • To review recent advancements in understanding the etiopathogenesis and immunopathology of primary Sjögren syndrome.
  • To highlight current and emerging therapeutic strategies for managing Sjögren syndrome.
  • To provide an overview of treatment options for both systemic and ocular manifestations.

Main Methods:

Related Experiment Videos

  • Literature review of recent studies on Sjögren syndrome.
  • Analysis of current therapeutic approaches, including systemic and medical/surgical treatments for dry eye.
  • Synthesis of information on disease mechanisms and management.

    • Main Results:

    • Recent research has expanded the understanding of primary Sjögren syndrome's underlying mechanisms and immunopathology.
    • Therapeutic options encompass systemic treatments (steroidal, nonsteroidal, disease-modifying, cytotoxic agents) and specific management for dry eye (aqueous enhancement, anti-inflammatory therapy, secretagogues, punctal occlusion, tarsorrhaphy, botulinum toxin).

    Conclusions:

    • Continued research is crucial for a deeper understanding of Sjögren syndrome's complex mechanisms.
    • A multifaceted approach combining systemic and targeted therapies is essential for effective patient management.
    • Advances in understanding offer improved therapeutic strategies for Sjögren syndrome patients.